To determine the signaling pathway involved in EPO-mediated phosphorylation of NRF2 in glaucoma, we assessed the ratio of phosphorylated to total PI3K, Akt, JNK, STAT1, STAT3, GSK3β, and MAPK (Figure 4). The gene discussed is EPO; the disease is glaucoma.